Drugs - Real World Outcomes is a peer-reviewed english-language open-access journal published by Adis, Springer Healthcare in United Kingdom, operating under an open-access model since 2014. The journal covers Therapeutics. Pharmacology and Pharmacy and materia medica.
Authors are required to pay an article processing charge to publish in Drugs - Real World Outcomes; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC license (see other journals using this license).
To date, Drugs - Real World Outcomes has published 544 articles. Articles are minted with DOIs through the prefix 10.1007. All submissions undergo plagiarism screening before peer review.
Keywords
big data, drug utilization, patient behaviour, real world healthcare
At a glance
- Publisher
- Adis, Springer Healthcare
- Country
- United Kingdom
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Anonymous peer review
- OA since
- 2014
- Review time
- 8 weeks
- DOI prefix
10.1007- Plagiarism check
- Yes
ISSN
- 2199-1154
- electronic
- 2198-9788
Frequently asked questions
Is Drugs - Real World Outcomes peer-reviewed?
Does Drugs - Real World Outcomes charge an article processing charge (APC)?
What subjects does Drugs - Real World Outcomes publish?
What languages does Drugs - Real World Outcomes accept?
What is the ISSN of Drugs - Real World Outcomes?
2199-1154 (print) · 2198-9788 (electronic).